ANTIBODY-MEDIATED REJECTION OF KIDNEY GRAFTS: COMPARISON OF STANDARD THERAPY AND THERAPY WITH ADDITION OF BORTEZOMIB AND/ OR RITUXIMAB

被引：0
|
作者：
Oblak, Teja [1 ]
Lindic, Jelka [1 ]
Kveder, Radoslav [1 ]
Rigler, Andreja Ales [1 ]
Skoberne, Andrej [1 ]
Haler, Zeljka Veceric [1 ]
Borstnar, Spela [1 ]
Avgustin, Nusa [1 ]
Gubensek, Jakob [1 ]
Ponikvar, Rafael [1 ]
Mlinsek, Gregor [1 ]
Ferluga, Dusan [2 ]
Kojc, Nika [2 ]
Kovac, Damjan [1 ]
机构：
[1] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia
[2] Univ Ljubljana, Inst Pathol, Med Fac, Ljubljana, Slovenia
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
MP059
引用
收藏
页码：386 / 386
页数：1
相关论文
共 50 条
  • [31] Rituximab-associated PRES in antibody-mediated kidney rejection: A case report
    Etemadifar, Masoud
    Alaei, Seyyed-Ali
    Saffari, Elahe
    Salari, Mehri
    TRANSPLANT IMMUNOLOGY, 2023, 80
  • [32] Comparison between bortezomib and rituximab in the treatment of antibody mediated renal allograft rejection
    Lachmann, N.
    Schoenemann, C.
    Budde, K.
    Schuetz, M.
    Liefeldt, L.
    Rudolph, B.
    Neumayer, H. -H.
    Waiser, J.
    TISSUE ANTIGENS, 2011, 77 (05): : 388 - 388
  • [33] COMPOSITE PROGNOSTIC SCORE IMPROVES CLINICAL BENEFIT IN KIDNEY RECIPIENTS RECEIVING STANDARD OF CARE THERAPY FOR ANTIBODY-MEDIATED REJECTION
    Viglietti, Denis
    Loupy, Alexandre
    Aubert, Olivier
    Legendre, Christophe
    Glotz, Denis
    Lefaucheur, Carmen
    TRANSPLANT INTERNATIONAL, 2017, 30 : 114 - 115
  • [34] Composite Prognostic Score Improves Clinical Benefit in Kidney Recipients Receiving Standard of Care Therapy for Antibody-Mediated Rejection
    Viglietti, D.
    Loupy, A.
    Aubert, O.
    Pillebout, E.
    Legendre, C.
    Glotz, D.
    Lefaucheur, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 309 - 309
  • [35] Bortezomib for Acute Antibody-Mediated Rejection in Liver Transplantation
    Paterno, F.
    Shiller, M.
    Tillery, G.
    O'Leary, J. G.
    Susskind, B.
    Trotter, J.
    Klintmalm, G. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (09) : 2526 - 2531
  • [36] Use of Eculizumab for Rescue Therapy of a Severe Antibody-Mediated Rejection in a Living Kidney Transplant
    Silvestre, C.
    Furian, L.
    Marson, P.
    Tison, T.
    Pierobon, E. S.
    Donato, P.
    Seveso, M.
    Valente, M. L.
    Cozzi, E.
    Rigotti, P.
    TRANSPLANTATION, 2012, 94 (10) : 1071 - 1071
  • [37] IS TREATMENT OF CHRONIC ANTIBODY-MEDIATED REJECTION BY BORTEZOMIB EFFECTIVE?
    Slatinska, Janka
    Honsova, Eva
    Rohal, Tomas
    Bohacova, Petra
    Hruba, Petra
    Viklicky, Ondrej
    TRANSPLANT INTERNATIONAL, 2017, 30 : 317 - 317
  • [38] Comparative Study of Bortezomib Therapy for Antibody Mediated Rejection.
    Macaluso, J.
    Killackey, M.
    Paramesh, A.
    Zhang, R.
    McGee, J.
    Slakey, D.
    Brock, G.
    Vehaskari, M.
    Cannon, R.
    Buell, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 160 - 160
  • [39] Bortezomib for Antibody-Mediated Rejection of Renal Transplant in Youth
    Galea, L.
    Hewlett, J.
    Savant, J.
    Lopez, S.
    Amaral, S.
    Viteri, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 723 - 723
  • [40] Bortezomib for antibody-mediated rejection of renal transplant in youth
    Galea, Lauren
    Hewlett, Jennifer
    Savant, Jon
    Lopez, Sonya
    Amaral, Sandra
    Viteri, Bernarda
    PEDIATRIC TRANSPLANTATION, 2022, 26
12345